Identification of HDM2 as a regulator of VEGF expression in cancer cells
- 20 June 2008
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 82 (25-26), 1231-1241
- https://doi.org/10.1016/j.lfs.2008.04.004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Detection of HDM2 and VEGF co-expression in cancer cell lines: novel effect of HDM2 antisense treatment on VEGF expressionLife Sciences, 2007
- HDM2-Binding Partners: Interaction with Translation Elongation Factor EF1αJournal of Proteome Research, 2007
- VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human CellsPublished by Elsevier BV ,2003
- Expression of Vascular Endothelial Growth Factor mRNA in GI-101A and HL-60 Cell LinesBiochemical and Biophysical Research Communications, 2000
- Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variantClinical Science, 1999
- MetastasisAmerican Scientist, 1998
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixJournal of Biological Chemistry, 1997
- Abnormal expression of MDM-2 in breast carcinomasBreast Cancer Research and Treatment, 1996
- Defining Protective Responses to Pathogens: Cytokine Profiles in Leprosy LesionsScience, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990